Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?
Arthritis & Rheumatology · 2026-03 · 78 (3) · 548-557
DOI: 10.1002/art.43427 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Arthritis & Rheumatology, online erschienen am 28.01.2026. Verfasst von Valentina Querin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Lupus Nephritis, C-Reactive Protein, Serum Amyloid P-Component, Kidney. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Lupus nephritis (LN) is characterized by a variable disease course, necessitating continuous monitoring. There is an urgent need to identify noninvasive biomarkers. By reviewing and critically assessing the quality of existing studies on LN biomarkers correlating with histopathology, we here explore the challenges in promoting their use in clinical practice and identify promising candidates for future validation.
Methods
A systematic literature search was conducted, including studies on adult patients with biopsy‐proven LN published between 2012 and 2024. The search focused on studies demonstrating correlations between biomarkers and histologic findings, particularly the National Institutes of Health activity and chronicity indices, the International Society of Nephrology/Renal Pathology Society histologic classes, and specific active and chronic lesions. The quality of selected articles was assessed by a multidisciplinary panel of experts using a standardized scoring system.
Results
Ninety‐three articles investigating the potential utility of >100 biomarkers were selected. In quality assessment, 68% of the articles were weak or very weak (score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
- Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Valentina Querin, David R W Jayne, Brad H Rovin, Augusto Vaglio, Ioannis Parodis
Zitieren
APA
Querin, V., Palazzo, L., Fogo, A. B., Haas, M., Jayne, D. R. W., Lightstone, L., Rovin, B. H., Seshan, S. V., Vaglio, A., Parodis, I., Bajema, I. M., & Lupus Nephritis Classification Steering Committee (2026). Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?. Arthritis & Rheumatology, 78(3), 548-557. https://doi.org/10.1002/art.43427
Vancouver
Querin V, Palazzo L, Fogo AB, Haas M, Jayne DRW, Lightstone L, et al. Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?. Arthritis & Rheumatology. 2026;78(3):548-557. doi:10.1002/art.43427
BibTeX
@article{Querin2026,
author = {Querin, Valentina and Palazzo, Leonardo and Fogo, Agnes B and Haas, Mark and Jayne, David R W and Lightstone, Liz and Rovin, Brad H and Seshan, Surya V and Vaglio, Augusto and Parodis, Ioannis and Bajema, Ingeborg M and Lupus Nephritis Classification Steering Committee, Lupus Nephritis Classification Steering Committee},
title = {Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?},
journal = {Arthritis & Rheumatology},
year = {2026},
volume = {78},
number = {3},
pages = {548--557},
doi = {10.1002/art.43427}
}
EUVIMED